MicroBase Technology Corp. (TPEX:3184)

Taiwan · Delayed Price · Currency is TWD

13.85

-0.85 (-5.78%)

Nov 6, 2026, 1:58 PM CST

Market Cap	873.58M +9.9%
Revenue (ttm)	210.93M -2.9%
Net Income	43.68M -8.6%
EPS	0.69 -7.4%
Shares Out	63.07M
PE Ratio	20.00
Forward PE	n/a
Dividend	0.22 (1.60%)
Ex-Dividend Date	Jul 13, 2026

Volume	195,826
Open	14.05
Previous Close	14.70
Day's Range	13.15 - 14.20
52-Week Range	8.40 - 35.90
Beta	0.70
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About MicroBase Technology

MicroBase Technology Corp. engages in the research, design, manufacture, and sale of components and products of micro-atomization and micro-needles for medical, cosmetic and electronic applications in Taiwan. The company develops non-silicon-based micro-electro-mechanical systems. It offers industrial inkjet head; soft mist inhaler, for the treatment of chronic obstructive pulmonary disease, Pocket Air, an aerosol drug delivery solution; and soluble and insoluble microneedles. MicroBase Technology Corp. was founded in 1997 and is based in Taoyu... [Read more]

Industry Electronic Components

Sector Technology

Founded 1997

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 3184

Full Company Profile

Financial Performance

In 2025, MicroBase Technology's revenue was 211.70 million, a decrease of -1.43% compared to the previous year's 214.76 million. Earnings were 30.14 million, a decrease of -56.59%.

Financial Statements